Regulation
US Congressional committee targets Sequoia's China exposure
Sequoia Capital has been targeted by a US Congressional committee seeking more details on its investments in semiconductors, quantum computing, and artificial intelligence (AI) in China over the past 13 years.
LPACs: Conflicts and complexity
The combination of a maturing Asian private equity landscape and a fast-emerging continuation fund opportunity is placing greater emphasis on the role of the LP advisory committee
China VC: Amicable divorces
Regulatory pressures are encouraging Chinese VC firms to end longstanding US affiliations, but the impact of impending legislation – even sight unseen – cuts deeper into investor sentiment on China
ESG backlash: Turbulent tailwinds
The strong momentum behind sustainable and responsible investment policies globally has begun to ruffle feathers in the US. Asian private equity should recognise this as a relevant warning
GGV to spin off Asia operation
GGV Capital’s Asia business will sever ties with the firm’s international operation – switching to separate partnerships and a distinct brand – as venture capital continues to feel the impact of the US and China’s conflicting technology agendas.
BlueRun Ventures China cuts ties with US brand
BlueRun Ventures China has been rebranded as Lanchi Ventures to differentiate itself from the Silicon Valley-headquartered VC firm with which it shares a name.
SEC votes through disclosure reforms for private funds
The US Securities and Exchange Commission (SEC) has adopted new transparency rules for private equity managers requiring increased reporting, special terms disclosure, and annual fund audits.
Biden clamps down on US investment in Chinese technology
US President Joe Biden has signed an executive order prohibiting outbound foreign investment in China that targets certain sensitive technologies, including semiconductors and microelectronics, quantum information technologies, and artificial intelligence...
China regulators look to streamline private equity oversight
Chinese Premier Li Qiang has signed off on new regulations aimed at facilitating private equity investment and guiding it into policy-aligned areas like semiconductors and biotech.
China's first US-listed SaaS company forced to delist
The New York Stock Exchange (NYSE) has suspended trading of China’s Cloopen and will apply to delist the software-as-a-service (SaaS) provider due to a failure to file its annual reports.
China: Who's investing?
Private equity investment in China remains in the doldrums yet local investors claim to see green shoots. Where, when, and how they engage with the market is likely to differ from previous cycles
Korea plans $751m venture capital fund-of-funds
The Korean government has sought to counter a steep drop-off in venture capital investment by pledging significant policy support for the industry, including a KRW 1trn (USD 751m) fund-of-funds.
Q&A: Vitalbridge Capital's Jinjian Zhang
Jinjian Zhang, founder of Chinese VC firm Vitalbridge Capital, on addressing domestic turbulence, getting investors to reengage on China, and where he sees opportunities in Southeast Asia
Top Chinese semiconductor investor released from detention
Datong Chen, co-founder of WestSummit Capital and one of China's foremost semiconductor investors, has been released by local authorities after eight months of detention.
HKEX relaxes rules for IPOs by pre-profit tech companies
The Hong Kong Stock Exchange (HKEX) has loosened its listing requirements to allow pre-profit technology companies to go public with market capitalisations as low as HKD 6bn (USD 764m).
China IPOs: Back to New York
With regulatory challenges receding, Chinese companies are once again targeting US listings. But the journey to New York – in terms of approvals, locations, and valuations – isn’t necessarily smooth
Regulator raises the qualification bar for Chinese GPs
China has introduced minimum paid-up capital requirements for local private equity firms that could force smaller, less sophisticated players out of the market.
Fan Bao cooperating with investigation - China Renaissance
Fan Bao, group chairman of China Renaissance, is “cooperating in an investigation being carried out by certain authorities” in China, the firm has announced.
Data sovereignty: Compliance complex
Deglobalisation is broadening the concept of cyber risk management from simply preventing attacks to navigating a minefield of data regulations. The pressure on PE spans investment, operations, and exits
China Renaissance founder Fan Bao goes missing
China Renaissance has confirmed it is unable to contact Fan Bao, the group’s chairman, executive director, CEO, and controlling shareholder.
Singapore to top-up SME co-investment programme
Singapore has earmarked an additional SGD 150m (USD 112m) for a co-investment fund that will invest in small and medium-sized enterprises (SMEs) as part of efforts to help local companies scale and become globally competitive.
China plans rollout of registration-based IPOs to all exchanges
China has proposed expanding the registration-based IPO system, which is intended to offer listing candidates lighter-touch regulation and a smoother path to the bourse, to all domestic stock markets.
Australia's Potentia contests Nitro merger plan
Potentia Capital has appealed a decision by Australia’s Takeovers Panel not to intervene in a situation that has seen Nitro Software repeatedly rebuff acquisition proposals made by the private equity firm.
PAG's Shan emphasizes diversity, control in Asia private equity
Momentum has shifted towards geographically diversified pan-regional investors, control deals, and private markets following a decade dominated by China-centric funds, growth-stage technology plays, and public equities, Weijian Shan, chairman and CEO...